Beautiful Virgin Islands


US Becomes 1st Country To Approve Respiratory Syncytial Virus Vaccine

US Becomes 1st Country To Approve Respiratory Syncytial Virus Vaccine

Drugmaker GSK's Arexvy was green-lighted for adults aged 60 and older, with similar shots from other makers including Pfizer and Moderna expected to follow soon.
*Your email address will not be displayed on website
Oh ya 349 days ago
Anyone willing to take another jab after what has come out about the deaths and injuries from the covid shot deserves everything they get. You cant fix stupid
Beautiful Virgin Islands
0:00
0:00
Close
×